Biotech · Private company
Yamo Pharmaceuticals LLC
Track this companyFree. Adds Yamo Pharmaceuticals LLC to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- L1-79Phase 2 · AutismClinicalTrials.gov · fetched Nov 12, 2026
- L1-79Phase 2 · Autism Spectrum DisorderClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A 12-Week Crossover Study to Assess the Efficacy, Safety and Tolerability of L1-79 in Subjects Aged 12-21 Years With Autism Spectrum DisorderPHASE2 · COMPLETED · started Jan 25, 2022ClinicalTrials.gov NCT05067582 · fetched Nov 12, 2026
- Safety of L1-79 in Adolescent and Adult Males With AutismPHASE2 · COMPLETED · started Oct 1, 2016ClinicalTrials.gov NCT02947048 · fetched Nov 12, 2026